Tocilizumab in Treatment of Severe COVID-19 Patients: A
Systematic Review and Meta-Analysis of Cohort Studies
Short running title: Tocilizumab for severe Covid-19
Mohamed Ahmed Elsokary PharmD1, Hozaifa Khalil Elsawah
PharmD, MSc1, Ahmed Hanei Elshafie
MSc2, Mahmoud S. Abdallah PhD3
1Department of Biostatistics, High Institute of Public
Health, Alexandria University, Alexandria, Egypt
2Department of Neuropsychiatry, Shebin Elkom Teaching
Hospital, Shebin Elkom, Egypt
3Department of Clinical Pharmacy, Faculty of Pharmacy,
University of Sadat City (USC), Sadat City, Menoufia, 32897, Egypt
Correspondence:
Mohamed Ahmed Elsokary, Alexandria University, Alexandria, Egypt.
ORCID: https://orcid.org/0000-0002-9832-5086
Email:
sokkary.mhmed@gmail.com
Present address
Mohamed Ahmed Elsokary, Quesna, Monofiya, 32631, Egypt